Skip to content

Celcuity CELC Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.62M+12.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.94M-60.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$293K+29,200%
CG Oncology logo
CG OncologyCGON
$2.68M-89.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$28.98M+39.5%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's other non-current assets?
Celcuity (CELC) reported other non-current assets of $603K in Q1 2026.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.